LDOS - Educational Analysis * US Equities
Educational Analysis * US Equities

LDOS

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerLDOS
CategoryEducational primer
Last reviewedOctober 19, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

Leidos Holdings, Inc. (LDOS) is listed in the Technology sector, specifically the Information Technology Services industry, but its operations are closer to a science, research and engineering contractor than a traditional commercial IT firm. Through its operating subsidiary Leidos, Inc., the company delivers digital and mission-focused solutions to U.S. government and commercial customers worldwide. It is organized into four reportable segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. In fiscal 2025, the revenue mix was National Security & Digital 44%, Health & Civil 30%, Commercial & International 13%, and Defense Systems 13%, while roughly 87% of total revenue came from U.S. government contracts as a prime or subcontractor and about 8% came from entities outside the United States.

The company’s reported profitability metrics are instructive. Leidos carries a net margin of 7.9% and a return on equity of 27.6%. A 27.6% ROE on a sub-8% net margin implies strong asset turnover and/or meaningful balance-sheet leverage working in shareholders’ favor—essentially, the business converts its contract backlog and cleared workforce into equity returns efficiently even though absolute profit per revenue dollar is modest by software standards. That combination is consistent with asset-heavy, project-based government services and systems engineering rather than high-margin, asset-light software licensing. Roughly 53% of employees hold U.S. security clearances and about 19% are military veterans, which acts as a practical barrier to entry: cleared talent is scarce, expensive to recruit, and hard to replicate quickly.

Financial posture

Leidos currently trades with a market capitalization of $15.9 billion and a price-to-earnings ratio of 11.7x. For a Technology-sector name, that P/E is on the lower end of what investors typically assign to IT services and software peers, reflecting the company’s dependence on federal procurement cycles and budget negotiations. Net margin of 7.9% is respectable for a large-scale contractor but not at the level often associated with pure-play software or cybersecurity vendors. The standout figure is ROE at 27.6%, which supports the idea that management has historically generated strong shareholder returns from its equity base.

The stock’s beta of 0.59 is also notable: it implies materially less market sensitivity than the average stock, which aligns with a revenue stream dominated by long-duration government contracts, annuity-like managed-health programs, and defense systems work. That low beta can cushion downside in broad market drawdowns, but it also suggests limited participation in technology-led rallies driven by commercial end-demand. Investors should view LDOS less as a high-growth tech play and more as a capital-efficient government-services franchise with a modest headline valuation.

Strategic priorities & outlook

Leidos’s most recent SEC 10-K filing lays out a clear operational agenda. Management is pursuing strategic growth across five pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. These pillars map well onto the segment mix—National Security & Digital and Defense Systems cover space/maritime, cyber, and mission software, while Health & Civil covers the managed health angle.

A near-term priority is to complete and successfully integrate the acquisition of Entrust (KENE Parent, Inc.) and capture the expected benefits. That deal adds identity, security, and digital-trust capabilities that complement the existing cyber and IT modernization portfolio. Separately, the company wants to grow its commercial health and infrastructure businesses, which are currently smaller than the government-facing operations. The 10-K also notes an emphasis on executing the broader business plan and long-term management initiatives while responding rapidly to emerging technology trends, including artificial intelligence. Company-funded research and development expense totaled $187 million in fiscal 2025, or about 1.1% of consolidated revenues—a modest reinvestment rate that again fits a services- and systems-integration model more than a product-led R&D engine.

Macro & geopolitical exposure

Because Leidos is classified as an Information Technology Services provider yet derives 87% of revenue from U.S. government contracts, its macro exposure is dominated by federal budget dynamics rather than by traditional commercial IT spending cycles. Debt-ceiling debates, continuing resolutions, appropriations delays, and shifts in defense, health, and civilian-agency priorities can influence contract awards, award timing, and program funding levels. Defense Systems and National Security & Digital revenue is exposed to Department of Defense budgets and geopolitical threat perceptions, while Health & Civil revenue is tied to federal health programs and to the regulatory environment around public-health IT.

The approximately 8% international revenue share adds currency and country-specific procurement risk, particularly in UK and allied defense programs. Recent contract language referencing UK defence logistics suggests some exposure to British military spending and NATO-related budgets. Trade policy, export controls, and foreign-currency translation can also matter for security-detection products and defense-system exports. On the cost side, a clearance-dependent workforce means competition for scarce labor and potential wage pressure, while supply-chain exposure exists around physical security-detection and aerospace/maritime systems. Finally, as a technology contractor deploying AI-enabled mission software, the company operates in an area of increasing regulatory and policy attention around data privacy, algorithmic accountability, and federal AI procurement standards.

Recent developments

The most recent news flow has centered on contract continuity and defense engagement. On October 14, 2026, PR Newswire reported that the UK Ministry of Defence extended Leidos’s LCST contract, continuing what the release described as critical logistics support to UK defence. That headline underscores the company’s international defense-services footprint and the recurring-contract nature of a portion of its revenue.

Earlier the same week, on October 12, 2026, Leidos announced its participation in the U.S. Army’s Reveille Forge “permanent hackathon,” according to PR Newswire, signaling ongoing positioning in cyber, mission software, and defense-technology innovation. Those two company-specific items appeared alongside Zacks.com commentary: on October 13, 2026, Zacks noted that Leidos had registered a bigger fall than the broader market, while on October 12, 2026, Zacks labeled Leidos a top-ranked growth stock. Those two pieces point to the same underlying tension the data already shows—consistent fundamental outperformance but mixed short-term price action.

Earnings behavior & post-earnings drift

Leidos has delivered a remarkably consistent earnings track record. Over the last eight reported quarters, it has beaten estimates in 8 out of 8 quarters, for a 100% beat rate, with an average earnings surprise of 16%. Despite that streak, the next-day stock reaction has not always been positive, which is a useful lesson in how expectations and positioning can shape post-earnings price action.

The four most recent quarters illustrate the point:

Averaged across the full eight-quarter history, the 5-day post-earnings drift is classified as “up,” with an average move of 2.15%. That positive drift, combined with the 100% beat rate and 16% average surprise, suggests the market has underappreciated Leidos’s earnings power more often than not, even if the immediate reaction sometimes goes the other way. The next scheduled report is November 3, 2026, before the market open, with a consensus EPS estimate of $3.04.

Frequently Asked Questions

What does Leidos actually do?

Leidos is a science, research and engineering company that provides digital and mission-focused solutions. Its largest segment is National Security & Digital, which produced 44% of fiscal 2025 revenue, followed by Health & Civil at 30%. About 87% of revenue comes from U.S. government contracts.

How has Leidos performed around earnings?

Over the last eight quarters, Leidos has beaten EPS estimates 100% of the time with an average surprise of 16%. The average 5-day post-earnings drift has been 2.15% to the upside, though the immediate next-day reaction has been mixed.

What are Leidos’s stated strategic priorities?

The 10-K identifies five growth pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. Management is also focused on integrating the Entrust acquisition and responding to AI-related technology trends.

For a deeper dive, consider reviewing the full institutional verdict, which aggregates analyst ratings, price-target dispersion, and revision trends alongside the earnings-history profile summarized above.

Real Data - Gamma QC Earnings IntelligenceAs of Oct 19, 2026
Leidos Holdings, Inc. · Technology / Information Technology Services
$15.9BMarket cap
11.7P/E
7.9%Net margin
27.6%ROE
100%Beat rate, last 8Q
16%Avg EPS surprise
2.15%Avg 5-day move after earnings
2026-11-03Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-08-04$3.26$2.91+12%-2.87%+7.88%
2026-05-05$3.13$2.9+7.9%-1.67%-6.41%
2026-02-17$2.76$2.61+5.7%+6.19%+7.8%
2025-11-04$3.05$2.71+12.5%-2.25%-0.65%
2025-08-05$3.21$2.66+20.7%--
2025-05-06$2.97$2.5+18.8%--

Previous LDOS editions

Beyond the primer

Get the institutional verdict on LDOS

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the LDOS verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.